Serum brain-derived neurotrophic factor (BDNF) and QEEG [quantitative electroencephalogram] as biological markers of response to (Es)citalopram treatment in major depressive disorder.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Citalopram (Primary) ; Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Biomarker; Therapeutic Use
- 11 May 2018 Biomarkers information updated
- 18 Aug 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 18 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.